Eligibility Criteria for Publicly-Funded Vaccines

Botulism antitoxin; DaPTP/Hib; DaPTP; Diphtheria antitoxin; DTPolio; Hib; ISG; MMR; IPV; Tetanus Immune Globulin; Td; TdPolio.

Eligibility criteria for these vaccines are found in The Canadian Immunization Guide (2002).

• children <5 years who are household contacts of acute cases and significant exposures as described in the Manitoba Health PEP Protocol.

• grade nine students (14-16 yrs. administered by Public Health Nurses in schools), individuals who are part-way through an immunization series started in another jurisdiction as part of a universal program

• clotting factor deficiencies, pediatric bone marrow transplants, contacts of Hepatitis A cases and persons in communities with a confirmed Hepatitis A outbreak (as determined by local Medical Officer of Health).

• grade four students (administered by Public Health Nurses in schools), infants born to infected/suspected infected mothers, sexual/household/needle or razor sharing contacts of acute & chronic cases of Hepatitis B, persons with multiple sexual partners or a recent history of a Sexually Transmitted Disease (STI), dialysis patients, frequent recipients of blood products, persons with a significant exposure as described in the Manitoba Health Post Exposure Protocol, individuals who are part-way through an immunization series started in another jurisdiction as part of a universal program, persons with Hepatitis C or chronic liver disease, offenders and new admissions to institutions for the developmentally challenged.

• men who have sex with men (MSM) or who are bisexual, intravenous drug users (IVDU), HCV or chronic liver disease and street-involved

• individuals at high-risk for influenza related complications: e.g.: adults & children (≥ 6 months of age) with chronic cardiac or pulmonary disorders, residents of personal care homes, healthy children 6-23 months, persons ≥ 65 years of age
• Adults and children who have any condition that can compromise respiratory function or the handling of respiratory secretions or that can increase the risk of aspiration.
• persons with diabetes mellitus and other metabolic diseases, cancer, immunodeficiency, immunosuppression (due to treatment or underlying disease),renal disease, anemia, hemoglobinopathy
• children and adolescents (6 mo. to 18 yrs) treated for long periods with acetylsalicylic acid
• individuals capable of transmitting the flu to those at high risk eg. health care workers, first responders, household contacts of children 0-23 months, daycare providers to children 0-23 months, pregnant women in their 3rd trimester expected to deliver during influenza season, and household contacts of people ≥ 65 years of age

• Grade 4 students born on or after January 1, 1995. This group will be offered the meningococcal conjugate C vaccine in schools by Public Health Nurses.
• Individuals at high risk including functional/anatomic asplenia (may include sickle cell anemia, thalassemia major, essential thrombocytopenia, celiac disease and inflammatory bowel disease, etc.)
• persons with terminal/alternative complement deficiencies
• individuals who are part-way through an immunization series started in another jurisdiction as part of a universal program
• contacts(s) of meningococcal serogroup C case (approved by Public Health)

• persons with terminal/alternative complement deficiencies
• functional/anatomic asplenia (may include sickle cell anemia, thalassemia major, essential thrombocytopenia, celiac disease and inflammatory bowel disease, etc.)

• Children <5 yrs. of age with one or more of:  functional or anatomic asplenia, immunosuppression/immunodeficiency, nephrotic syndrome,
• chronic cardiac disease, chronic pulmonary disease (excluding asthma not requiring high dose steroids), CSF leak, poorly controlled diabetes
• cochlear implant recipients, renal failure
• Children born on or after January 1, 2004
• individuals who are part-way through an immunization series started in another jurisdiction as part of a universal program

 
• Sickle cell disease, congenital or acquired asplenia, splenic dysfunction, dialysis, nephritic syndrome, multiple myeloma, residents of long term care facilities, congenital immune deficiencies, SCID, chronic CSF leaks, immunosuppressed, cochlear implant recipients
• persons ≥ 65 years of age
• persons 2 to 64 years of age with chronic underlying illness including renal, liver, cardiac, or pulmonary disease, HIV infection, autoimmune disease on high-dose steroids and chemotherapy agent, malignancies including Hodgkin’s and non-Hodgkin’s lymphomas and poorly controlled diabetes mellitus.

• persons with occupational or activity related risks: e.g.: taxidermists, trappers, spelunkers, working with injured wildlife, conservation officers, veterinarian assistants, animal control officers. Business/pleasure travellers to rabies endemic countries are not eligible.
• high-risk occupational related travel e.g. zoologists working in rabies endemic country.

• approval by Medical Officer of Health

• approval by Medical Officer of Health

• High-risk susceptible persons: as described in the Canadian Immunization Guide (2002) with cystic fibrosis who are receiving long term acetylsalicylic acid therapy and who are immunocompromised
• Susceptible household contacts of such persons, whether the high-risk person can be safely immunized or not.
• Infants (12 months of age) born on or after January 1, 2004, children born on or after January 1, 1999 at the time of their preschool booster, grade 4 students. The Public Health Nurses will offer the varicella vaccine to grade 4 students in schools.
• individuals who are part-way through an immunization series started in another jurisdiction as part of a universal program

NOTE:  Vaccines for travel, occupational health, or educational reasons are not provided by Manitoba Health.  To obtain these vaccines and Mantoux solution (testing for tuberculosis), contact your local travel clinic or pharmacy concerning availability and cost.

Communicable Disease Control (CDC) Unit  Public Health Branch Manitoba Health 4th Floor - 300 Carlton St. Winnipeg MB  R3B 3M9  CANADA Phone: (204) 788-6737 Fax: (204) 948-2040	See also:  Manitoba's Routine Childhood Immunization Schedule for Infants and Children.